Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
University of Pittsburgh
University of Pittsburgh
University of Pittsburgh
Hummingbird Bioscience
University of Chicago
Maia Biotechnology
Istituto Oncologico Veneto IRCCS
AVEO Pharmaceuticals, Inc.
KaliVir Immunotherapeutics
Alpha Tau Medical LTD.
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Hôpital NOVO
Eli Lilly and Company
National Institutes of Health Clinical Center (CC)
Wake Forest University Health Sciences
M.D. Anderson Cancer Center
AstraZeneca
Memorial Sloan Kettering Cancer Center
National Institutes of Health Clinical Center (CC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Dutch Society of Physicians for Pulmonology and Tuberculosis
M.D. Anderson Cancer Center
Neonc Technologies, Inc.
Seoul National University Bundang Hospital
Azienda Ospedaliero-Universitaria di Parma
UNC Lineberger Comprehensive Cancer Center
University of Colorado, Denver
VLP Therapeutics
Maia Biotechnology
University of Pittsburgh
Institut de Cancérologie de Lorraine
Mayo Clinic
Memorial Sloan Kettering Cancer Center
Alpha Tau Medical LTD.
Alpha Tau Medical LTD.
University of Chicago
Radboud University Medical Center
New York University
Universitair Ziekenhuis Brussel
ImmVira Pharma Co. Ltd
Insel Gruppe AG, University Hospital Bern
Vanderbilt-Ingram Cancer Center
Vanderbilt-Ingram Cancer Center
Samsung Medical Center
Bruce Robinson, MD
Geisinger Clinic
Bicara Therapeutics
Dana-Farber Cancer Institute
University of Pittsburgh
University of Pittsburgh